Newsroom

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

  • Dana-Farber Blog

    • Insight Blog screenshot Insight features the latest in cancer care and research news from Dana-Farber.
    • Read the blog

  • Dana-Farber Facts

    • Dana-Farber 2012 Facts brochureFind statistics on Dana-Farber's patient care, fundraising initiatives and achievements, and phone numbers for patients and families.
    • View Dana-Farber Facts

  • Dana-Farber View Book

    • Dana-Farber 2011 Viewbook coverThis 24-page magazine gives an overview of Dana-Farber, focusing on its equal investment in research and patient care.
    • View Dana-Farber View Book 
     

  • The Cancer Treatment Revolution

    • The Cancer Treatment Revolution book cover Dr. David Nathan, acclaimed pediatric hematologist and Dana-Farber's president from 1995 – 2000, recounts that history's triumphs and struggles in his book, The Cancer Treatment Revolution.
     

Newsroom

Multimedia

Dana-Farber Spotlight

Sign up to receive Dana-Farber Spotlight, our monthly email newsletter.
View this month's issue
Subscribe now
Unsubscribe from mailings

Media Contacts

Bill Schaller
Director of Media Relations
617-632-4090
william_schaller
@dfci.harvard.edu 

Molly McHale
Associate Director of Media Relations
617-632-4090
molly_mchale
@dfci.harvard.edu 

 

Top News Releases

Paths of Progress Spring Summer 2012 cover
Celebrating Oncology Nurses logo
  • May 14, 2012
  • Dana-Farber Cancer Institute recognizes Oncology Nursing Month
  • During Oncology Nursing Month, Dana-Farber proudly recognizes its dedicated, expert nursing professionals, who serve many functions along the continuum of care. Our nurses also received recognition from national peers and local patients.
Levi A. Garraway, MD, PhD
William G. Kaelin, Jr., MD
  • May 02, 2012
  • American Society for Clinical Investigation honors Kaelin
  • William G. Kaelin, Jr., MD, received the 2012 American Society for Clinical Investigation’s Stanley J. Korsmeyer Award in recognition of his contributions to the molecular understanding of cellular oxygen sensing and cellular adaptation to hypoxia.
See all news releases >

Dana Farber In the News

  • Cancer's epicentre (The Economist)
  • Epigenetics was the subject of a particularly interesting session, held on April 1st, at a meeting of the American Association for Cancer Research in Chicago. James Bradner, MD, described how his group has shown that a substance known as JQ1, which inhibits an epigenetic regulator called BRD4, blocks the activity of a gene by the name of Myc.
  • Breast cancer hot topic: Clear tumor margins (abcnews.com)
  • Breast cancer surgeons have been having an ongoing discussion on how much tissue to breast tissue to remove when removing a tumor. Dr. Mehra Golshan said that with ductal carcinoma in situ (DCIS), a very treatable, early stage cancer, smaller margins are acceptable and appropriate.
See all media coverage >

Publications

See all publications >


Content